Positive association between perfluoroalkyl chemicals and hyperuricemia in children

American Journal of Epidemiology

Volumn 177, Issue 11, 2013, Pages 1255-1262

  Geiger, Sarah Dee ^a   Xiao, Jie ^b   Shankar, Anoop ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b NONE

Author keywords

hyperuricemia; NHANES; pediatrics; perfluoroalkyl chemicals; perfluorooctane sulfonate; perfluorooctanoic acid; PFC; uric acid

Indexed keywords

PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; URIC ACID;

CHILD HEALTH; COMPARATIVE STUDY; DISEASE PREVALENCE; HEALTH MONITORING; HEALTH RISK; HEALTH SERVICES; MULTIVARIATE ANALYSIS; NATIONAL SECURITY; SERUM;

ADOLESCENT; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; ETHNIC DIFFERENCE; FEMALE; HEALTH SURVEY; HUMAN; HYPERURICEMIA; INCOME; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; UNITED STATES; URIC ACID BLOOD LEVEL;

HYPERURICEMIA; NHANES; PEDIATRICS; PERFLUOROALKYL CHEMICALS; PERFLUOROOCTANE SULFONATE; PERFLUOROOCTANOIC ACID; PFC; URIC ACID;

ADOLESCENT; ALKANESULFONIC ACIDS; CAPRYLATES; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; FLUOROCARBONS; HUMANS; HYPERURICEMIA; MALE; NUTRITION SURVEYS; UNITED STATES; URIC ACID;

UNITED STATES;

EID: 84878525830     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws392     Document Type: Article

References (50)

1. Lau C, Anitole K, Hodes C, et al. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci. 2007;99(2):366-394.
2. Steenland K, Fletcher T, Savitz DA. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect. 2010;118(8):1100-1108.
3. Calafat AM,Wong LY, Kuklenyik Z, et al. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect. 2007;115(11):1596-1602.
4. Begley TH, White K, Honigfort P, et al. Perfluorochemicals: potential sources of and migration from food packaging. Food Addit Contam. 2005;22(10):1023-1031.
5. Ericson I, Nadal M, van Bavel B, et al. Levels of perfluorochemicals in water samples from Catalonia, Spain: is drinking water a significant contribution to human exposure? Environ Sci Pollut Res Int. 2008;15(7):614-619.
6. Guo Z, Liu X, Krebs K. Perfluorocarboxylic Acid Content in 116 Articles of Commerce. Research Triangle Park, NC: Environmental Protection Agency; 2009.
7. Kubwabo C, Stewart B, Zhu J, et al. Occurrence of perfluorosulfonates and other perfluorochemicals in dust from selected homes in the city of Ottawa, Canada. J Environ Monit. 2005;7(11):1074-1078.
8. Martin JW, Muir DC, Moody CA, et al. Collection of airborne fluorinated organics and analysis by gas chromatography/chemical ionization mass spectrometry. Anal Chem. 2002; 74(3):584-590.
9. Shoeib M, Harner T, Ikonomou M, et al. Indoor and outdoor air concentrations and phase partitioning of perfluoroalkyl sulfonamides and polybrominated diphenyl ethers. Environ Sci Technol. 2004;38(5):1313-1320.
10. Clarke DB, Bailey VA, Routledge A, et al. Dietary intake estimate for perfluorooctanesulphonic acid (PFOS) and other perfluorocompounds (PFCs) in UK retail foods following determination using standard addition LC-MS/MS. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2010; 27(4):530-545.
11. Schecter A, Colacino J, Haffner D, et al. Perfluorinated compounds, polychlorinated biphenyls, and organochlorine pesticide contamination in composite food samples from Dallas, Texas, USA. Environ Health Perspect. 2010;118(6): 796-802.
12. Trudel D, Horowitz L,Wormuth M, et al. Estimating consumer exposure to PFOS and PFOA. Risk Anal. 2008; 28(2):251-269.
13. Glantzounis GK, Tsimoyiannis EC, Kappas AM, et al. Uric acid and oxidative stress. Curr Pharm Des. 2005;11(32): 4145-4151.
14. Proctor P. Electron-transfer factors in psychosis and dyskinesia. Physiol Chem Phys. 1972;4(4):349-360.
15. Terkeltaub RA. Clinical practice. Gout. N Engl J Med. 2003;349(17):1647-1655.
16. Lin SD, Tsai DH, Hsu SR. Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Assoc. 2006;69(11):512-516.
17. Kang DH, Park SK, Lee IK, et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16(12):3553-3562.
18. Facchini F, Chen YD, Hollenbeck CB, et al. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA. 1991;266(21):3008-3011.
19. Bandaru P, Shankar A. Association between serum uric acid levels and diabetes mellitus. Int J Endocrinol. 2011;2011:604715.
20. Shankar A, Klein R, Klein BE, et al. The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study. J Hum Hypertens. 2006; 20(12):937-945.
21. Cain L, Shankar A, Ducatman AM, et al. The relationship between serum uric acid and chronic kidney disease among Appalachian adults. Nephrol Dial Transplant. 2010;25(11): 3593-3599.
22. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES I Epidemiologic Follow-up Study, 1971-1992. National Health and Nutrition Examination Survey. JAMA. 2000;283(18):2404-2410.
23. Hongo M, Hidaka H, Sakaguchi S, et al. Association between serum uric acid levels and cardiometabolic risk factors among Japanese junior high school students. Circ J. 2010;74 (8):1570-1577.
24. Alper AB Jr, ChenW, Yau L, et al. Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension. 2005;45(1):34-38.
25. Chang HY, Pan WH, YehWT, et al. Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96). J Rheumatol. 2001;28(7):1640-1646.
26. Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension. 2003;42(3):247-252.
27. Feig DI, Kang DH, Nakagawa T, et al. Uric acid and hypertension. Curr Hypertens Rep. 2006;8(2):111-115.
28. Lee MS,Wahlqvist ML, Yu HL, et al. Hyperuricemia and metabolic syndrome in Taiwanese children. Asia Pac J Clin Nutr. 2007;16(suppl 2):594-600.
29. Costa G, Sartori S, Consonni D. Thirty years of medical surveillance in perfluooctanoic acid production workers. J Occup Environ Med. 2009;51(3):364-372.
30. Sakr CJ, Kreckmann KH, Green JW, et al. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. J Occup Environ Med. 2007;49(10): 1086-1096.
31. Sakr CJ, Leonard RC, Kreckmann KH, et al. Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate. J Occup Environ Med. 2007;49(8):872-879.
32. Steenland K, Tinker S, Shankar A, et al. Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA. Environ Health Perspect. 2010;118(2): 229-233.
33. Seals R, Bartell SM, Steenland K. Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community. Environ Health Perspect. 2011;119(1):119-124.
34. Robinson R. The fetal origins of adult disease. BMJ. 2001; 322(7283):375-376.
35. Solomons NW. Programme and policy issues related to promoting positive early nutritional influences to prevent obesity, diabetes and cardiovascular disease in later life: a developing countries view. Matern Child Nutr. 2005;1(3): 204-215.
36. National Center for Health Statistics, Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey 2003-2004: reference manuals and reports. Atlanta, GA: Centers for Disease Control and Prevention; 2010. (http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/nhanes03- 04htm). (Accessed October 22, 2010).
37. National Center for Health Statistics, Centers for Disease Control and Prevention. Laboratory procedure manual for uric acid. Atlanta, GA: Centers for Disease Control and Prevention; 2010. (http://www.cdc.gov/nchs/data/nhanes/ nhanes-03-04/l40-c-met-uric-acidpdf). (Accessed October 22, 2010).
38. Ford ES, Li C, Cook S, et al. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation. 2007;115(19): 2526-2532.
39. Asayama K, Ozeki T, Sugihara S, et al. Criteria for medical intervention in obese children: a new definition of 'obesity disease' in Japanese children. Pediatr Int. 2003;45(5): 642-646.
40. Behrman RE, Kliegman R, Jenson H. Nelson Textbook of Pediatrics. 17th ed. Philadelphia, PA: Saunders; 2004.
41. Deboer MD, Gurka MJ. Low sensitivity for the metabolic syndrome to detect uric acid elevations in females and non-Hispanic-black male adolescents: an analysis of NHANES 1999-2006. Atherosclerosis. 2012;220(2): 575-580.
42. Centers for Disease Control and Prevention. Growth chart training. Atlanta, GA: Centers for Disease Control and Prevention; 2011. (http://www.cdc.gov/nccdphp/dnpao/growthcharts/resources/sas htm). (Accessed May 17, 2012).
43. National Center for Health Statistics, Centers for Disease Control and Prevention. Procedures for laboratory components of NHANES. Atlanta, GA: Centers for Disease Control and Prevention; 2010. (http://www.cdc.gov/nchs/data/nhanes/ nhanes-03-04/blood03-04 pdf). (Accessed October 22, 2010).
44. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811-1821.
45. Shankar A, Xiao J, Ducatman A. Perfluoroalkyl chemicals and elevated serum uric acid in US adults. Clin Epidemiol. 2011;3:251-258.
46. Frisbee SJ, Shankar A, Knox SS, et al. Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project. Arch Pediatr Adolesc Med. 2010;164(9):860-869.
47. Hoffman K,Webster TF,Weisskopf MG, et al. Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of age. Environ Health Perspect. 2010;118(12): 1762-1767.
48. Eraly SA, Vallon V, Rieg T, et al. Multiple organic anion transporters contribute to net renal excretion of uric acid. Physiol Genomics. 2008;33(2):180-192.
49. Panaretakis T, Shabalina IG, Grander D, et al. Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid. Toxicol Appl Pharmacol. 2001;173(1):56-64.
50. Yao X, Zhong L. Genotoxic risk and oxidative DNA damage in HepG2 cells exposed to perfluorooctanoic acid. Mutat Res. 2005;587(1-2):38-44.